Study of pulmonary function tests in patients of diabetes mellitus (NIDDM) with chronic obstructive pulmonary disease or asthma

Table of Contents

1. INTRODUCTION

2. AIMS AND OBJECTIVES

3. REVIEW OF LITERATURE

4. MATERIAL AND METHODS

5. RESULTS

6. DISCUSSION

7. SUMMARY AND CONCLUSION

Research Objectives and Focus

This study aims to assess and compare pulmonary function parameters (including spirometry, lung volumes, and diffusing capacity) in patients with Type 2 diabetes mellitus (NIDDM) who suffer from comorbid chronic obstructive pulmonary disease (COPD) or asthma, while correlating these findings with disease severity, glycemic control, and health-related quality of life.

• Evaluation of pulmonary function in diabetic patients with comorbid airway diseases.
• Correlation between lung function metrics (DLCO, lung volumes) and airflow limitation.
• Relationship between glycemic control (HbA1c) and respiratory health.
• Assessment of impairment in health-related quality of life (HRQoL) using standardized questionnaires.

Excerpt from the Book

Summary of Chapters

1. INTRODUCTION: Provides an overview of diabetes as a systemic disease and introduces the hypothesis that the lungs are a target organ for complications induced by hyperglycemia.

2. AIMS AND OBJECTIVES: Outlines the specific goals of the research, focusing on the evaluation and correlation of pulmonary functions in diabetic patients with obstructive lung diseases.

3. REVIEW OF LITERATURE: Traces the historical understanding of diabetes, COPD, and asthma, and summarizes previous clinical research regarding lung function in diabetic patients.

4. MATERIAL AND METHODS: Describes the study design, patient recruitment across specific departments, definitions of diseases, and the methodology for pulmonary and biochemical testing.

5. RESULTS: Presents the statistical findings regarding age, gender, glycemic control, and the comparative analysis of various pulmonary function test parameters across the study groups.

6. DISCUSSION: Interprets the findings of the study in relation to existing scientific literature and explores the pathophysiological implications of the observed lung function abnormalities.

7. SUMMARY AND CONCLUSION: Recaps the study findings and concludes that spirometry in diabetic patients with obstructive airway diseases should be confirmed with DLCO and plethysmography.

Keywords

Diabetes Mellitus, Type 2 Diabetes, NIDDM, COPD, Asthma, Pulmonary Function Tests, Spirometry, DLCO, Lung Volumes, Plethysmography, Glycemic Control, HbA1c, Microangiopathy, Health-Related Quality of Life, SGRQ.

Frequently Asked Questions

What is the core subject of this research?

The study investigates the pulmonary function profiles of patients with Type 2 diabetes mellitus (NIDDM) who also have comorbid chronic obstructive pulmonary disease (COPD) or asthma.

What are the primary areas of interest within the study?

The study focuses on spirometric performance, diffusing capacity of the lungs (DLCO), static lung volumes, the impact of glycemic control on lung function, and the overall quality of life of these patients.

What is the main objective of the research?

The primary aim is to evaluate pulmonary function parameters in diabetic patients with airway obstruction and to correlate these with the severity of lung disease, the duration of diabetes, and patient quality of life.

Which scientific methodology was employed?

The study utilized a comparative analysis of three groups (Diabetics with COPD, Diabetics with Asthma, and healthy controls) performing spirometry, body plethysmography, and DLCO tests, analyzed via statistical ANOVA and correlation methods.

What does the main body of the work cover?

The main body examines historical literature, clinical diagnostic definitions, detailed experimental methods for lung assessment, and an extensive statistical analysis of the patient data collected between 2006 and 2008.

Which keywords define this study?

The study is characterized by terms such as Diabetes Mellitus, COPD, Asthma, Pulmonary Function Tests, DLCO, and Health-Related Quality of Life.

Why were the participants divided into three specific groups?

The grouping into diabetic patients with COPD (Group A), diabetic patients with asthma (Group B), and healthy controls (Group C) allows for direct comparative analysis of the pulmonary impact of the comorbid conditions relative to a baseline.

What were the major conclusions reached by the author?

The author concludes that spirometry results in diabetic patients with obstructive diseases are variable and should be confirmed with more advanced tests like DLCO and plethysmography to accurately assess the restrictive components of their condition.